Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb:136:7-15.
doi: 10.1016/j.diabres.2017.11.019. Epub 2017 Nov 26.

Comparison of adiposity indicators associated with fasting-state insulinemia, triglyceridemia, and related risk biomarkers in a nationally representative, adult population

Henry S Kahn  1 , Yiling J Cheng  2
Affiliations

Comparison of adiposity indicators associated with fasting-state insulinemia, triglyceridemia, and related risk biomarkers in a nationally representative, adult population

Henry S Kahn et al. Diabetes Res Clin Pract. 2018 Feb.

Abstract

Aims: We hypothesized that height-corrected abdominal size (supine sagittal abdominal diameter/height ratio [SADHtR] or waist circumference/height ratio [WHtR]) would associate more strongly than body mass index (BMI, weight/height2) with levels of fasting insulin, triglycerides, and three derived biomarkers of insulin resistance.

Methods: Anthropometry, including SAD by caliper, was collected on 4398 adults in the 2011-2014 National Health and Nutrition Examination Survey. For comparison purposes, each adiposity indicator was scaled to its population-based, sex-specific, interquartile range (IQR). For each biomarker we created four outcome groups based on equal-sized populations with ascending values. Multivariable polytomous logistic regression modeled the relationships between the adiposity indicators and each biomarker.

Results: Highest-group insulin was associated with a one-IQR increment of BMI (RR 4.3 [95% CI 3.9-4.9]), but more strongly with a one-IQR increment of SADHtR (RR 5.7 [5.0-6.6]). For highest-group HOMA-IR the RR for BMI (4.2 [3.7-4.6]) was less than that of SADHtR (6.0 [5.1-7.0]). Similarly, RRs for BMI were smaller than those for SADHtR applying to highest-group triglycerides (RR 1.6 vs 2.1), triglycerides/HDL-cholesterol (RR 1.9 vs 2.4) and TyG index (RR 1.7 vs 2.2) (all p < .001). The RRs for WHtR were consistently between those for SADHtR and BMI. The top 25% of insulin resistance among US adults was estimated to lie above adiposity thresholds of 0.140 for SADHtR, 0.606 for WHtR, or 29.6 kg/m2 for BMI.

Conclusions: Relative abdominal size rather than relative weight may better define adiposity associated with homeostatic insulin resistance. These population-based, cross-sectional findings could improve anthropometric prediction of cardiometabolic risk.

Keywords: Anthropometry; Body mass index; Insulin resistance; Obesity, abdominal; Sagittal abdominal diameter; Waist-height ratio.

PubMed Disclaimer

Conflict of interest statement

Declaration of interest

The authors declare that there is no conflict of interest associated with this manuscript.

Figures

Fig. 1
Fig. 1
Measurement of the sagittal abdominal diameter (SAD) in a supine participant. Reprinted from Kahn HS et al. [50] with permission from Elsevier.
Fig. 2
Fig. 2
Risk ratios associated with SADHtR, WHtR, or BMI for being in ascending biomarker groups (Q1 through Q4) of fasting insulin or HOMA-IR. Models (sample n = 4251) are adjusted for age, ancestry, use of injected insulin, and use of oral antiglycemic medication. Error bars show the 95% CI. a p < 0.01 for comparison to BMI. b p < 0.001 for comparison to BMI.
Fig. 3
Fig. 3
Risk ratios associated with SADHtR, WHtR, or BMI for being in ascending biomarker groups (Q1 through Q4) of lipid-based biomarkers (proxy variables for insulin resistance). Models (sample n = 4353) are adjusted for age, ancestry, and sex. Error bars show the 95% CI. a p < 0.01 for comparison to BMI. b p < 0.001 for comparison to BMI.
See this image and copyright information in PMC

References

    1. Bastien M, Poirier P, Lemieux I, Despres JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014;56:369–81. - PubMed
    1. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359:2105–20. - PubMed
    1. Wannamethee SG, Papacosta O, Whincup PH, Carson C, Thomas MC, Lawlor DA, et al. Assessing prediction of diabetes in older adults using different adiposity measures: a 7 year prospective study in 6,923 older men and women. Diabetologia. 2010;53:890–8. - PMC - PubMed
    1. World Health Organization. Waist circumference and waist– hip ratio: Report of a WHO expert consultation; Geneva. 8–11 December, 2008; Geneva, Switzerland: WHO; 2011. [cited 16 October 2017]. Available from: http://apps.who.int/iris/bitstream/10665/44583/1/9789241501491_eng.pdf.
    1. Freisling H, Arnold M, Soerjomataram I, O’Doherty MG, Ordonez-Mena JM, Bamia C, et al. Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe. Br J Cancer. 2017;116:1486–97. - PMC - PubMed